[新型冠状病毒肺炎中的体外膜肺氧合]
[Extracorporeal membrane oxygenation in COVID-19].
作者信息
Carboni Bisso Indalecio, Garbarini Melina, Lockhart Carolina, Villarroel Sonia, Chas José, Kotowicz Vadim, San Román Eduardo, Las Heras Marcos
机构信息
Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires.
Cirugía Cardiovascular, Hospital Italiano de Buenos Aires.
出版信息
Rev Fac Cien Med Univ Nac Cordoba. 2022 Mar 7;79(1):65-68. doi: 10.31053/1853.0605.v79.n1.29337.
INTRODUCTION
The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to pulmonary rehabilitation, in patients that have refractory hypoxemic respiratory failure with recovery potential, the use of ECMO could also be beneficial.
OBJECTIVE
The purpose of this work is to report the first case of COVID-19 that required ECMO in Argentina, with a good response.
METHODOLOGY
We describe the first case of COVID-19 that required ECMO in Argentina, in a patient without comorbidities, with good clinical results.
RESULTS
The use of ECMO in the reported case provided a substantial benefit in oxygenation, acting as a bridge to lung recovery, without presenting complications associated with its application.
CONCLUSION
In critically ill patients with refractory hypoxemia, but with high recovery potential, ECMO support can be considered as a rescue measure.
引言
体外膜肺氧合（ECMO）在冠状病毒病（COVID-19）患者中的作用正在讨论中。在急性呼吸窘迫综合征（ARDS）患者中，ECMO是一种常用的挽救措施，用于优化氧合作为肺康复的桥梁，而对于有恢复潜力的难治性低氧性呼吸衰竭患者，使用ECMO也可能有益。
目的
本文旨在报告阿根廷首例需要ECMO治疗且反应良好的COVID-19病例。
方法
我们描述了阿根廷首例需要ECMO治疗的COVID-19病例，该患者无合并症，临床效果良好。
结果
在所报告的病例中，使用ECMO在氧合方面带来了显著益处，起到了肺恢复桥梁的作用，且未出现与应用相关的并发症。
结论
对于患有难治性低氧血症但恢复潜力高的重症患者，可考虑将ECMO支持作为一种挽救措施。
Zotero 插件